Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia.

Nealon J, Lim WY, Moureau A, Linus Lojikip S, Junus S, Kumar S, Nachiappan JP, Devi Sekaran S, Radigue C, Cowling BJ, Ochiai RL, Hss AS.

Vaccine. 2019 Sep 16;37(39):5891-5898. doi: 10.1016/j.vaccine.2019.07.083. Epub 2019 Aug 21.

2.

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.

Pasin C, Halloran ME, Gilbert PB, Langevin E, Ochiai RL, Pitisuttithum P, Capeding MR, Carrasquilla G, Frago C, Cortés M, Chambonneau L, Moodie Z.

PLoS One. 2018 Dec 13;13(12):e0207878. doi: 10.1371/journal.pone.0207878. eCollection 2018.

3.

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).

L'Azou M, Assoukpa J, Fanouillere K, Plennevaux E, Bonaparte M, Bouckenooghe A, Frago C, Noriega F, Zambrano B, Ochiai RL, Guy B, Jackson N.

Trans R Soc Trop Med Hyg. 2018 Apr 1;112(4):158-168. doi: 10.1093/trstmh/try037. Review.

4.

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.

Plennevaux E, Moureau A, Arredondo-García JL, Villar L, Pitisuttithum P, Tran NH, Bonaparte M, Chansinghakul D, Coronel DL, L'Azou M, Ochiai RL, Toh ML, Noriega F, Bouckenooghe A.

Clin Infect Dis. 2018 Apr 3;66(8):1164-1172. doi: 10.1093/cid/cix966.

5.

A recombinant live attenuated tetravalent vaccine for the prevention of dengue.

Guy B, Noriega F, Ochiai RL, L'azou M, Delore V, Skipetrova A, Verdier F, Coudeville L, Savarino S, Jackson N.

Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1335201. Epub 2017 Jun 7. Review. Erratum in: Expert Rev Vaccines. 2017 Jul;16(7):ix.

PMID:
28590795
6.

Barriers to typhoid fever vaccine access in endemic countries.

Khan MI, Franco-Paredes C, Sahastrabuddhe S, Ochiai RL, Mogasale V, Gessner BD.

Res Rep Trop Med. 2017 Mar 10;8:37-44. doi: 10.2147/RRTM.S97309. eCollection 2017. Review.

7.

Symptomatic Dengue in Children in 10 Asian and Latin American Countries.

L'Azou M, Moureau A, Sarti E, Nealon J, Zambrano B, Wartel TA, Villar L, Capeding MR, Ochiai RL; CYD14 Primary Study Group; CYD15 Primary Study Group.

N Engl J Med. 2016 Mar 24;374(12):1155-66. doi: 10.1056/NEJMoa1503877.

8.

A comparative study on active and passive epidemiological surveillance for dengue in five countries of Latin America.

Sarti E, L'Azou M, Mercado M, Kuri P, Siqueira JB Jr, Solis E, Noriega F, Ochiai RL.

Int J Infect Dis. 2016 Mar;44:44-9. doi: 10.1016/j.ijid.2016.01.015. Epub 2016 Feb 2.

9.

Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan.

Khan MI, Pach A 3rd, Khan GM, Bajracharya D, Sahastrabuddhe S, Bhutta W, Tahir R, Soofi S, Thapa CB, Joshi N, Puri MK, Shrestha P, Upreti SR, Clemens JD, Bhutta Z, Ochiai RL.

Vaccine. 2015 Jun 19;33 Suppl 3:C62-7. doi: 10.1016/j.vaccine.2015.03.087. Epub 2015 Apr 30. Review.

PMID:
25937612
10.

The contribution of neighbours to an individual's risk of typhoid outcome.

Chao DL, Park JK, Marks F, Ochiai RL, Longini IM, Halloran ME.

Epidemiol Infect. 2015 Dec;143(16):3520-7. doi: 10.1017/S0950268815000692. Epub 2015 May 4.

11.

Typhoid fever.

Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL.

Lancet. 2015 Mar 21;385(9973):1136-45. doi: 10.1016/S0140-6736(13)62708-7. Epub 2014 Oct 21. Review.

PMID:
25458731
12.

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment.

Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, Kim YE, Park JK, Wierzba TF.

Lancet Glob Health. 2014 Oct;2(10):e570-80. doi: 10.1016/S2214-109X(14)70301-8. Erratum in: Lancet Glob Health. 2014 Dec;2(12):e696.

13.

Estimating the burden of paratyphoid a in Asia and Africa.

Arndt MB, Mosites EM, Tian M, Forouzanfar MH, Mokhdad AH, Meller M, Ochiai RL, Walson JL.

PLoS Negl Trop Dis. 2014 Jun 5;8(6):e2925. doi: 10.1371/journal.pntd.0002925. eCollection 2014 Jun.

14.

Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review.

Mogasale V, Desai SN, Mogasale VV, Park JK, Ochiai RL, Wierzba TF.

PLoS One. 2014 Apr 17;9(4):e93784. doi: 10.1371/journal.pone.0093784. eCollection 2014. Review.

15.

Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India.

Ochiai RL, Khan MI, Soofi SB, Sur D, Kanungo S, You YA, Habib MA, Sahito SM, Manna B, Dutta S, Acosta CJ, Ali M, Bhattacharya SK, Bhutta ZA, Clemens JD.

Clin Vaccine Immunol. 2014 May;21(5):661-6. doi: 10.1128/CVI.00791-13. Epub 2014 Mar 5.

16.

25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal.

Bajracharya D, Khan MI, Pach A 3rd, Shrestha P, Joshi N, Upreti SR, Wierzba T, Puri M, Sahastrabuddhe S, Ochiai RL.

PLoS One. 2014 Jan 6;9(1):e77974. doi: 10.1371/journal.pone.0077974. eCollection 2014.

17.

Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study.

Punjabi NH, Agtini MD, Ochiai RL, Simanjuntak CH, Lesmana M, Subekti D, Oyofo BA, von Seidlein L, Deen J, Shin S, Acosta C, Wangsasaputra F, Pulungsih SP, Saroso S, Suyeti S, R S, Sudarmono P, Syarurachman A, Suwandono A, Arjoso S, Beecham HJ 3rd, Corwin AL, Clemens JD.

J Infect Dev Ctries. 2013 Nov 15;7(11):781-7. doi: 10.3855/jidc.2629.

18.

Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.

Sahastrabuddhe S, Carbis R, Wierzba TF, Ochiai RL.

Expert Rev Vaccines. 2013 Sep;12(9):1021-31. doi: 10.1586/14760584.2013.825450. Review.

PMID:
24053396
19.

Vivax malaria and bacteraemia: a prospective study in Kolkata, India.

Bhattacharya SK, Sur D, Dutta S, Kanungo S, Ochiai RL, Kim DR, Anstey NM, von Seidlein L, Deen J.

Malar J. 2013 May 31;12:176. doi: 10.1186/1475-2875-12-176.

20.

Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan.

Pach A, Tabbusam G, Khan MI, Suhag Z, Hussain I, Hussain E, Mumtaz U, Haq IU, Tahir R, Mirani A, Yousafzai A, Sahastrabuddhe S, Ochiai RL, Soofi S, Clemens JD, Favorov MO, Bhutta ZA.

J Health Commun. 2013;18(3):306-24. doi: 10.1080/10810730.2012.727958. Epub 2013 Jan 18.

PMID:
23330632
21.

Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: assessment of the performance of the WHO case definitions.

Thriemer K, Ley B, Ame SS, Deen JL, Pak GD, Chang NY, Hashim R, Schmied WH, Busch CJ, Nixon S, Morrissey A, Puri MK, Ochiai RL, Wierzba T, Clemens JD, Ali M, Jiddawi MS, von Seidlein L, Ali SM.

PLoS One. 2012;7(12):e51823. doi: 10.1371/journal.pone.0051823. Epub 2012 Dec 20. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/18ab2cda-9bb4-45ca-ae9c-517654f8160d. Ley, Benedikt B [corrected to Ley, Benedikt].

22.

Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan.

Khan MI, Soofi SB, Ochiai RL, Khan MJ, Sahito SM, Habib MA, Puri MK, Von Seidlein L, Park JK, You YA, Ali M, Nizami SQ, Acosta CJ, Sack RB, Clemens JD, Bhutta ZA.

J Infect Dev Ctries. 2012 Oct 19;6(10):704-14. doi: 10.3855/jidc.1967.

23.

Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.

Khan MI, Soofi SB, Ochiai RL, Habib MA, Sahito SM, Nizami SQ, Acosta CJ, Clemens JD, Bhutta ZA; DOMI Typhoid Karachi Vi Effectiveness Study Group.

Vaccine. 2012 Aug 3;30(36):5389-95. doi: 10.1016/j.vaccine.2012.06.015. Epub 2012 Jun 18.

PMID:
22721899
24.

The burden of invasive bacterial infections in Pemba, Zanzibar.

Thriemer K, Ley B, Ame S, von Seidlein L, Pak GD, Chang NY, Hashim R, Schmied WH, Busch CJ, Nixon S, Morrissey A, Puri MK, Ali M, Ochiai RL, Wierzba T, Jiddawi MS, Clemens JD, Ali SM, Deen JL.

PLoS One. 2012;7(2):e30350. doi: 10.1371/journal.pone.0030350. Epub 2012 Feb 17.

25.

Replacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, Zanzibar.

Thriemer K, Ley B, Ame SM, Puri MK, Hashim R, Chang NY, Salim LA, Ochiai RL, Wierzba TF, Clemens JD, von Seidlein L, Deen JL, Ali SM, Ali M.

BMC Res Notes. 2012 Feb 21;5:113. doi: 10.1186/1756-0500-5-113.

26.

High-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata.

Holt KE, Dutta S, Manna B, Bhattacharya SK, Bhaduri B, Pickard DJ, Ochiai RL, Ali M, Clemens JD, Dougan G.

PLoS Negl Trop Dis. 2012 Jan;6(1):e1490. doi: 10.1371/journal.pntd.0001490. Epub 2012 Jan 31.

27.

Schools as potential vaccination venue for vaccines outside regular EPI schedule: results from a school census in Pakistan.

Soofi SB, Haq IU, Khan MI, Siddiqui MB, Mirani M, Tahir R, Hussain I, Puri MK, Suhag ZH, Khowaja AR, Lasi AR, Clemens JD, Favorov M, Ochiai RL, Bhutta ZA.

BMC Res Notes. 2012 Jan 6;5:6. doi: 10.1186/1756-0500-5-6.

28.

Decreasing incidence of severe malaria and community-acquired bacteraemia among hospitalized children in Muheza, north-eastern Tanzania, 2006-2010.

Mtove G, Amos B, Nadjm B, Hendriksen IC, Dondorp AM, Mwambuli A, Kim DR, Ochiai RL, Clemens JD, von Seidlein L, Reyburn H, Deen J.

Malar J. 2011 Oct 27;10:320. doi: 10.1186/1475-2875-10-320.

29.

Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India.

Ali M, Sur D, Kim DR, Kanungo S, Bhattacharya SK, Manna B, Ochiai RL, Clemens J.

Vaccine. 2011 Nov 8;29(48):9051-6. doi: 10.1016/j.vaccine.2011.09.027. Epub 2011 Sep 20.

PMID:
21939716
30.

Enteric vaccines for resource-limited countries: current status and future prospects.

Desai SN, Sahastrabuddhe S, Ochiai RL, Wierzba TF.

Pediatr Ann. 2011 Jul;40(7):351-7. doi: 10.3928/00904481-20110615-07. No abstract available.

PMID:
21736257
31.

Risk factors associated with typhoid fever in children aged 2-16 years in Karachi, Pakistan.

Khan MI, Ochiai RL, Soofi SB, Von-Seidlein L, Khan MJ, Sahito SM, Habib MA, Puri MK, Park JK, You YA, Ali M, Nizami SQ, Acosta CJ, Bradley-Sack R, Clemens JD, Bhutta ZA.

Epidemiol Infect. 2012 Apr;140(4):665-72. doi: 10.1017/S0950268811000938. Epub 2011 May 31.

PMID:
21676350
32.

New advances in typhoid Fever vaccination strategies.

Bhutta ZA, Khan MI, Soofi SB, Ochiai RL.

Adv Exp Med Biol. 2011;697:17-39. doi: 10.1007/978-1-4419-7185-2_3. Review. No abstract available.

PMID:
21120717
33.

Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysis.

Ali M, Sur D, Lopez AL, Kanungo S, Ochiai RL, Manna B, Kim DR, Deen J, Bhattacharya SK, Clemens JD.

J Health Popul Nutr. 2010 Oct;28(5):450-7.

34.

Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004.

Dong BQ, Yang J, Wang XY, Gong J, von Seidlein L, Wang ML, Lin M, Liao HZ, Ochiai RL, Xu ZY, Jodar L, Clemens JD.

Bull World Health Organ. 2010 Sep 1;88(9):689-96. doi: 10.2471/BLT.09.069310. Epub 2010 Apr 7.

35.

Use of verbal autopsy to determine mortality patterns in an urban slum in Kolkata, India.

Kanungo S, Tsuzuki A, Deen JL, Lopez AL, Rajendran K, Manna B, Sur D, Kim DR, Gupta VK, Ochiai RL, Ali M, von Seidlein L, Bhattacharya SK, Clemens JD.

Bull World Health Organ. 2010 Sep 1;88(9):667-74. doi: 10.2471/BLT.09.073742. Epub 2010 May 21.

36.

Non-typhoidal Salmonella rates in febrile children at sites in five Asian countries.

Khan MI, Ochiai RL, von Seidlein L, Dong B, Bhattacharya SK, Agtini MD, Bhutta ZA, Do GC, Ali M, Kim DR, Favorov M, Clemens JD.

Trop Med Int Health. 2010 Aug;15(8):960-3. doi: 10.1111/j.1365-3156.2010.02553.x. Epub 2010 Jun 9.

37.

Population impact of Vi capsular polysaccharide vaccine.

Khan MI, Ochiai RL, Clemens JD.

Expert Rev Vaccines. 2010 May;9(5):485-96. doi: 10.1586/erv.10.43. Review.

PMID:
20450323
38.

Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies.

Mtove G, Amos B, von Seidlein L, Hendriksen I, Mwambuli A, Kimera J, Mallahiyo R, Kim DR, Ochiai RL, Clemens JD, Reyburn H, Magesa S, Deen JL.

PLoS One. 2010 Feb 16;5(2):e9244. doi: 10.1371/journal.pone.0009244.

39.

Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata India.

Sur D, Manna B, Chakrabarty N, Kaljee LM, Riel R, Pach A, Kanungo S, Deen J, Ochiai RL, Clemens J, Bhattacharya SK.

Hum Vaccin. 2009 Sep;5(9):614-20. Epub 2009 Sep 22.

PMID:
19652547
40.

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD.

N Engl J Med. 2009 Jul 23;361(4):335-44. doi: 10.1056/NEJMoa0807521.

41.

Typhoid vaccination: the Asian experience.

DeRoeck D, Ochiai RL, Yang J, Anh DD, Alag V, Clemens JD.

Expert Rev Vaccines. 2008 Jul;7(5):547-60. doi: 10.1586/14760584.7.5.547. Review.

PMID:
18564010
42.

A study of typhoid fever in five Asian countries: disease burden and implications for controls.

Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, Bhutta ZA, Canh DG, Ali M, Shin S, Wain J, Page AL, Albert MJ, Farrar J, Abu-Elyazeed R, Pang T, Galindo CM, von Seidlein L, Clemens JD; Domi Typhoid Study Group.

Bull World Health Organ. 2008 Apr;86(4):260-8. Erratum in: Bull World Health Organ. 2015 Apr 1;93(4):284. Bull World Health Organ. 2015 Jun 1;93(6):440.

43.

Adults' perceived prevalence of enteric fever predicts laboratory-validated incidence of typhoid fever in children.

Chen X, Stanton B, Pach A, Nyamete A, Ochiai RL, Kaljee L, Dong B, Sur D, Bhattacharya SK, Santoso SS, Agtini M, Memon Z, Bhutta Z, Do CG, von Seidlein L, Clemens J.

J Health Popul Nutr. 2007 Dec;25(4):469-78.

44.

Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.

Dutta S, Sur D, Manna B, Sen B, Bhattacharya M, Bhattacharya SK, Wain J, Nair S, Clemens JD, Ochiai RL.

Int J Antimicrob Agents. 2008 Apr;31(4):387-9. doi: 10.1016/j.ijantimicag.2007.12.004. Epub 2008 Feb 15. No abstract available.

PMID:
18280709
45.

Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.

Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Nga TT, Van Vinh Chau N, Tuan PQ, Page AL, Ochiai RL, Schultsz C, Wain J, Bhutta ZA, Parry CM, Bhattacharya SK, Dutta S, Agtini M, Dong B, Honghui Y, Anh DD, Canh DG, Naheed A, Albert MJ, Phetsouvanh R, Newton PN, Basnyat B, Arjyal A, La TT, Rang NN, Phuong LT, Van Be Bay P, von Seidlein L, Dougan G, Clemens JD, Vinh H, Hien TT, Chinh NT, Acosta CJ, Farrar J, Dolecek C.

Antimicrob Agents Chemother. 2007 Dec;51(12):4315-23. Epub 2007 Oct 1.

46.

Spatial risk for gender-specific adult mortality in an area of southern China.

Ali M, Jin Y, Kim DR, De ZB, Park JK, Ochiai RL, Dong B, Clemens JD, Acosta CJ.

Int J Health Geogr. 2007 Jul 24;6:31.

47.

The use of typhoid vaccines in Asia: the DOMI experience.

Ochiai RL, Acosta CJ, Agtini M, Bhattacharya SK, Bhutta ZA, Do CG, Dong B, Chen X, Stanton B, Kaljee L, Nyamete A, Galindo CM, von Seidlein L, DeRoeck D, Jodar L, Clemens JD.

Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S34-8.

PMID:
17582567
48.

Geographic analysis of vaccine uptake in a cluster-randomized controlled trial in Hue, Vietnam.

Ali M, Thiem VD, Park JK, Ochiai RL, Canh DG, Danovaro-Holliday MC, Kaljee LM, Clemens JD, Acosta CJ.

Health Place. 2007 Sep;13(3):577-87. Epub 2007 Jan 24.

PMID:
17254831
49.

Optimizing typhoid fever case definitions by combining serological tests in a large population study in Hechi City, China.

Dong B, Galindo CM, Shin E, Acosta CJ, Page AL, Wang M, Kim D, Ochiai RL, Park J, Ali M, Seidlein LV, Xu Z, Yang J, Clemens JD.

Epidemiol Infect. 2007 Aug;135(6):1014-20. Epub 2007 Jan 12.

50.

Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam.

Kaljee LM, Pham V, Son ND, Hoa NT, Thiem VD, Canh DG, Thoa le TK, Ali M, Ochiai RL, Danovaro-Holliday MC, Acosta CJ, Stanton B, Clemens J.

Trop Med Int Health. 2007 Jan;12(1):25-36.

Supplemental Content

Loading ...
Support Center